MYX 0.46% $4.38 mayne pharma group limited

BOOK value $7.60 per share, page-20

  1. 166 Posts.
    lightbulb Created with Sketch. 95
    Gee you write some silly stuff, and spewing it out to smother any *sensible* conversation.

    You can not *save* OpEx when you are comparing a completely different company. The one benefit of the TxMD transaction was utilising the existing, expensive and under utilised Nextstellis Sales force + $20m additional.

    The Share Price doesn't lie. You may not like it, and I may not like it, but MYX didn't meet market expectations in their FY results, all eyes will be on cashflow and a + EBITDA result 1H


 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.